Biomarkers of kidney disease

Clinical applications for biomarkers include monitoring illness activity, diagnosing it, managing molecularly targeted therapies, and monitoring therapy response. Glomerular filtration rate (GFR) continues to be the ideal indicator of renal health. Kidney damage atoms and lipocalin associated with neutrophil gelatinase are thought to be useful biomarkers in plasma and urine to assess the severity and prognosis of Chronic Kidney Disease.

  • Decompensated heart failure

Related Conference of Biomarkers of kidney disease

June 13-14, 2024

9th World Kidney Congress

Barcelona, Spain
July 25-26, 2024

28th European Nephrology Conference

Frankfurt, Germany
October 03-04, 2024

22nd International Conference on Nephrology, Urology and Therapeutics

Singapore City, Singapore

Biomarkers of kidney disease Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in